Neratinib in HER2-Positive Breast Cancer With Brain Metastases

J Clin Oncol. 2021 Jan 20;39(3):251-252. doi: 10.1200/JCO.20.02385. Epub 2020 Dec 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Brain Neoplasms* / drug therapy
  • Breast Neoplasms* / drug therapy
  • Female
  • Humans
  • Quinolines*
  • Receptor, ErbB-2

Substances

  • Quinolines
  • Receptor, ErbB-2
  • neratinib